Search Results - "Barbudo del Cura, E"

Program to Integral Attention of Obesity of Infanta Leonor Hospital by Banzo Arguis, C, Martinez de Velasco Soriano, R, Felix Alcantara, M, Perez-Templado Ladrón de Guevara, M.J, Barbudo del Cura, E, Quintero Gutierrez del Álamo, F.J

“…INTRODUCTION Obesity is a high prevalent disease with great impact in life quality and can become a risk factor to development of other health problems. Most…”
Get full text

P03-35 - The evolution in the nosological conception of the ganser syndrom by Jiménez Gómez, B, Chapela Herrero, E, Navas Tejedor, M, Fernández Rojo, S, Mora Minguez, F, Barbudo del Cura, E, Gutierrez del Álamo, J.Q

“…The Ganser syndrome has been evolving more in terms of the nosological conception than in relation to its clinic characteristics, with the hypothesis of a…”
Get full text

The evolution in the nosological conception of the ganser syndrom by Jiménez Gómez, B., Chapela Herrero, E., Navas Tejedor, M., Fernández Rojo, S., Mora Minguez, F., Barbudo del Cura, E., Gutierrez del Álamo, J.Q.

“…The Ganser syndrome has been evolving more in terms of the nosological conception than in relation to its clinic characteristics, with the hypothesis of a…”
Get full text

328 – Efficacy of the combination of amisulpride and quetiapine in the treatment of refractory schizophrenia by Mur De Víu, C, Del Alamo, F.J. Quintero Gutiérrez, Domínguez, A. Ceverino, Lauffer, J. Correas, Bermudo-Soriano, C. Riaza, Vigo, M. Martínez, Del Cura, E. Barbudo, Molina, J. De Dios, Resa, E. García, Lequerica, A. Sánchez, Villamor, I. Basurte, Piñeiro, M. Vega, García, E. Baca, Vicente, J. Sevilla, Revuelta, J.L. González De Rivera Y

Get full text

Addiction characteristics as prognostic factors in opiate dependence treated with naltrexone by Madoz-Gúrpide, A, Barbudo del Cura, E, Leira Sanmartín, M, Navio Acosta, M, Villoria Borrego, L, Ochoa Mangado, E

“…Addiction characteristics as prognostic factors in opiate dependence treatment were studied. Thus, several factors related to previous opiate consumption…”
Get more information

Abuse, tolerance and dependence of zolpidem: three case reports by Correas Lauffer, J, Braquehais Conesa, D, Barbudo Del Cura, E, Ochoa Mangada, E

“…Zolpidem is an imidazopyridine, which acts at the benzodiacepine omega1 receptor subtype. Zolpidem was marketed as a short-acting hypnotic and it was assumed…”
Get more information